Nutini S, Cappelli G, Benucci A, Catalani C, Nozzoli F
Pneumology Unit, USL 10/D, Firenze, Italy.
Int J Biol Markers. 1990 Oct-Dec;5(4):198-202.
The significance of neuron specific enolase (NSE) was investigated in comparison with other tumor markers (CEA, CT, CA 15-3) used in the diagnosis and treatment monitoring of lung cancer. As previously described, the calcitonin assay proved to have very low sensitivity for small cell lung cancer (SCLC). The serum NSE assay was, however, shown to be a useful diagnostic aid for discrimination between histologically different lung cancers, and therefore this assay may be a valuable tool for treatment monitoring in SCLC patients. CA 15-3, also an unspecific marker, showed similar sensitivity to the NSE assay in SCLC patients, the sensitivity being higher than CEA in non small cell lung cancer (NSCLC).
与用于肺癌诊断和治疗监测的其他肿瘤标志物(癌胚抗原、降钙素、糖类抗原15-3)相比,研究了神经元特异性烯醇化酶(NSE)的意义。如前所述,降钙素检测对小细胞肺癌(SCLC)的敏感性非常低。然而,血清NSE检测被证明是区分组织学上不同肺癌的有用诊断辅助手段,因此该检测可能是SCLC患者治疗监测的有价值工具。同样是非特异性标志物的糖类抗原15-3,在SCLC患者中显示出与NSE检测相似的敏感性,其敏感性在非小细胞肺癌(NSCLC)中高于癌胚抗原。